Informatie:
Fout:
ID
34156
Beschrijving
Blood Test for Breast Cancer Associated Auto Antibodies; ODM derived from: https://clinicaltrials.gov/show/NCT01343849
Link
https://clinicaltrials.gov/show/NCT01343849
Trefwoorden
Versies (1)
- 14-01-19 14-01-19 -
Houder van rechten
GSK group of companies
Geüploaded op
14 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT01343849
Eligibility Breast Cancer NCT01343849
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT01343849
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
female subjects 18 years or over.
boolean
ID.2
Item
subjects suspected of breast cancer. the clinical suspicion will include one of the following: positive mammography, ultrasound (us), magnetic resonance imaging (mri), suspected physical exam. final analysis will be done in relation to pathology only.
boolean
ID.3
Item
subjects scheduled biopsy/surgery
boolean
ID.4
Item
female subjects less than 18 years of age
boolean
ID.5
Item
previous or concurrent malignancies
boolean
ID.6
Item
autoimmune disorders diagnosed subjects
boolean
ID.7
Item
hematological malignancies
boolean
ID.8
Item
subjects under active chemotherapy treatment or chemotherapy in the past 6 months
boolean
ID.9
Item
steroid treatment in the past 3 months
boolean
ID.10
Item
subject undergoing immunosuppressive treatments
boolean